|
|
 |
|
Viewing report
|
|
|
|
European Contrast Media and Radiopharmaceutical Market
Frost & Sullivan, Dec 2009, Pages: 156
The research service attempts to spot trends, identify market dynamics and challenges and evaluate the European contrast media and radiopharmaceuticals market. The study presents market forecasts along with the competitive analysis
This Frost & Sullivan research service titled European Contrast Media and Radiopharmaceutical Market provides a comprehensive analysis of the challenges affecting the European contrast media and radiopharmaceuticals market, factors driving and restraining growth and the opportunities that participants can capitalise on up to 2012. In this research, Frost & Sullivan's expert analysts thoroughly examine the following regions: Germany, France, Italy, Spain, The United Kingdom, Benelux and Scandinavia.
This analysis is available through our Medical Imaging Growth Partnership Services programme. With continuous access to intelligence and resources from all seven perspectives of the Complex Business Universe, the Growth Partnership Services program ensures that you and your Growth Team™ are able to maintain a 360 Degree Perspective of the market. This comprehensive, objective information allows your company to mitigate risk, identify new opportunities, and drive effective strategies for growth.
Market Overview
Greater Knowledge on the Benefits of Using Contrasting Agents in Diagnosing Diseases Drives the European Contrast Media and Radiopharmaceutical Market
Contrast media are substances used to boost the contrast of structures and fluids in diagnostic imaging such as x-ray, computed tomography (CT), magnetic resonance imaging (MRI) and ultrasound imaging. Greater awareness about these agents among radiologists and physicians is leading to increased utilisation of imaging equipment and a consequent rise in the demand for contrast media due to the application of contrasting agents in diagnosing diseases related to cardiology, respiratory and urology.
“There has been a significant rise in the number of modalities across Europe and a consequent growth in the number of procedures,” says the analyst of this research. “With a greater number of procedures, the volume of usage of contrast media steps up automatically; thereby promoting the growth of the contrast media market.” There is a perceptible change in the attitude of physicians, who now seem ready to adapt themselves to new technology procedures that are likely to assist them to diagnose better. These new nuclear medicine procedures are enhancing the overall growth of the radiopharmaceuticals market.
However, radioactive agents used in diagnostic and therapeutic procedures have a short half-life period and need to be used before they lose their radioactivity, making them less favourable than other non-nuclear imaging modalities. “The radioactive isotope producing site should be relatively close to the installation of the scanner,” explains the analyst. “Furthermore, the protection and disposal of the agents are important as the European countries are particular about safety standards.” End users should be made aware about the effectiveness, safety and overall developments in imaging procedures. This will facilitate brand building and customer loyalty, apart from a competitive edge over other participants. The companies should also collaborate with academic institutions and training facilities for greater nuclear medicine awareness amongst the medical fraternity.
Market Sectors
Expert Frost & Sullivan analysts thoroughly examine the following market sectors in this research:
By Region:
- Germany
- France
- Italy
- Spain
- The United Kingdom
- Benelux
- Scandinavia
Product samples
A sample for this product is available. Please Login/Register to download this sample.
Customers who bought this item also bought
Imaging Agents - Global Strategic Business Report
European Ultrasound Market - Upper Body Applications
European Remote Patient Monitoring Market
Analysis of the European Thrombosis Therapeutics Market
European Ultrasound Market - Lower Body Applications
European Markets for Interventional Radiology and Cardiology
European Markets for Digital and Computed Radiography
European Women's Healthcare Imaging Markets
European Markets for Ultrasound
European Markets for Assisted Living Technologies
|
|
|
|
